Introduction to Syneos Health UK

Syneos Health UK stands as a premier partner in the healthcare and life sciences ecosystem, delivering integrated clinical and commercial solutions that expedite the journey of novel therapies from concept to market. Headquartered in the United Kingdom with a global footprint spanning over 110 countries, Syneos Health UK operates at the intersection of clinical research, regulatory strategy, and market access, serving as a trusted ally for pharmaceutical, biotechnology, and medical device organizations. The company’s UK division, with its main office in Bracknell, England, has cultivated a reputation for excellence, leveraging deep local expertise while maintaining alignment with the parent organization’s robust global infrastructure. With revenues exceeding $4 billion globally and a workforce of approximately 30,000 employees worldwide, Syneos Health UK contributes significantly to the European clinical trial landscape, managing thousands of studies across therapeutic areas including oncology, neuroscience, immunology, and rare diseases. The UK subsidiary is recognized by industry analysts for its hybrid model—blending clinical research organization (CRO) capabilities with contract commercial organization (CCO) services—which allows clients to streamline drug development and commercialization under one umbrella. This unique positioning enables Syneos Health UK to offer end-to-end support, from early-phase clinical trials to post-approval real-world evidence generation, making it a preferred partner for both emerging biotech firms and top 20 pharmaceutical companies. The company’s commitment to regulatory excellence is underscored by its strong relationships with the Medicines and Healthcare products Regulatory Agency (MHRA) and adherence to International Council for Harmonisation (ICH) guidelines, ensuring that every study conducted meets the highest standards of safety and data integrity. Furthermore, Syneos Health UK’s investment in digital innovation—such as decentralized clinical trial platforms, artificial intelligence-driven patient recruitment, and real-world data analytics—positions it as a forward-thinking leader in the rapidly evolving healthcare landscape. Organizations that choose Syneos Health UK gain access to a vast network of investigators, sites, and patient communities across the UK and Europe, combined with localized regulatory expertise that accelerates approvals and market entry. The company’s culture of collaboration, ethical conduct, and scientific rigor has earned it multiple accolades, including recognition as a top employer in the CRO industry by Science Magazine and consistently high ratings on employee review platforms. For professionals seeking a career in clinical research, Syneos Health UK offers unparalleled opportunities to work on cutting-edge therapies, contribute to global health outcomes, and grow within a supportive, innovation-driven environment.

Company History and Business Evolution

Syneos Health was formed in 2017 through the merger of two industry stalwarts: INC Research and inVentiv Health, each with decades of history in clinical research and commercialization. INC Research, founded in 1994, had established itself as a leading CRO specializing in central nervous system and oncology trials, while inVentiv Health, founded in 1999, brought deep expertise in contract commercial services and market access. The merger created a unique hybrid organization capable of offering both clinical development and commercial solutions under a single brand. Syneos Health UK traces its roots to the establishment of a dedicated European hub following the merger, building upon existing operations from both legacy companies. The UK office initially focused on managing the growing demand for European trial sites, with teams in Bracknell and London overseeing regulatory submissions, patient recruitment, and data management. Over the years, Syneos Health UK expanded its capabilities through strategic acquisitions, including the purchase of leading UK-based CROs specializing in early-phase studies and real-world evidence. In 2019, the company launched its decentralized clinical trial (DCT) unit in the UK, enabling remote patient monitoring and digital data collection, which proved invaluable during the COVID-19 pandemic. The pandemic further accelerated Syneos Health UK’s digital transformation, with the rapid deployment of virtual trial tools, telehealth platforms, and AI-driven analytics to maintain continuity of critical studies. Post-pandemic, the UK division has focused on scaling its offerings in cell and gene therapies, leveraging partnerships with academic medical centers and NHS hospitals to facilitate complex trial designs. Recent milestones include the opening of a state-of-the-art clinical logistics center in Bracknell and the launch of a community engagement program to improve diversity in clinical trials. As of 2025, Syneos Health UK continues to innovate, investing in biomarker discovery, patient-centric trial designs, and regulatory intelligence services that help clients navigate the evolving European medicines landscape. The company’s evolution from a traditional CRO to a integrated clinical and commercial powerhouse reflects broader industry trends toward consolidation, digitalization, and value-based healthcare. Today, Syneos Health UK is recognized as a top-tier partner for biopharma companies seeking to accelerate time-to-market while reducing costs and risk.

Syneos Health UK at a Glance

• Headquarters (UK): Bracknell, Berkshire, England
• Global Headquarters: Morrisville, North Carolina, USA
• Founded: 2017 (via merger of INC Research and inVentiv Health)
• CEO: Michelle Keefe (Global), UK Managing Director: Dr. Sarah Thompson
• Revenue (Global): $4.5 billion (2024)
• Employees (Global): 30,000+; UK: 2,500+
• Industry Classification: Clinical Research Organization (CRO) / Contract Commercial Organization (CCO)
• Key Therapeutic Areas: Oncology, Neuroscience, Immunology, Rare Diseases, Infectious Diseases, Cardiovascular
• Specialties: Full-service clinical trials, regulatory affairs, market access, patient recruitment, real-world evidence, digital health
• Global Presence: Operations in 110+ countries
• UK Offices: Bracknell (HQ), London, Manchester, Edinburgh
• Certifications: ISO 9001, ISO 27001, FDA compliant, MHRA registered
• Accreditations: IQVIA partnership, NHS Digital approval
• Technology: Syneos ONE platform, AI-enabled trial optimization, decentralized trial tools
• Awards: Top CRO to Work For (Science), Best Place to Work (Glassdoor), Clinical Research Innovation Award
• Publicly Traded: Yes (NASDAQ: SYNH)
• Client Base: Top 20 pharmaceutical companies, emerging biotechs, medical device companies
• Notable Partnerships: NHS Foundation Trusts, European Medicines Agency (EMA) liaison
• Recent Developments: Launch of patient diversity program, expansion in cell & gene therapy
• Social Impact: Commitment to carbon neutrality by 2030, community health initiatives

Mission, Vision, and Core Corporate Values

Syneos Health UK’s mission is to accelerate the development and commercialization of innovative therapies that improve patient lives globally. The vision is to be the most trusted partner in healthcare, seamlessly integrating clinical and commercial expertise to bring life-changing treatments to market faster. Core corporate values include: Integrity – maintaining the highest ethical standards in all interactions; Innovation – embracing digital technologies and novel trial designs; Collaboration – fostering teamwork across internal teams and with clients; Excellence – delivering quality data and regulatory compliance; and Patient Centricity – placing patients at the heart of every decision. These values are embedded in daily operations, from how employees interact with colleagues and clients to the design of clinical protocols that minimize patient burden. Syneos Health UK also champions diversity and inclusion, actively recruiting from underrepresented groups and implementing policies that promote equity across all levels. The company’s commitment to sustainability is reflected in its green office initiatives, reduced travel through virtual site visits, and partnerships with eco-conscious vendors.

Business Strategy and Future Roadmap

Syneos Health UK’s business strategy centers on three pillars: digital transformation, therapeutic depth, and client intimacy. Digital transformation involves leveraging artificial intelligence, machine learning, and real-world data to optimize trial design, patient recruitment, and site selection. The company’s Syneos ONE platform integrates clinical and commercial data to provide real-time insights. Therapeutic depth focuses on building expertise in high-growth areas like oncology, neuroscience, and rare diseases, where the UK has a strong scientific base. Client intimacy means understanding each client’s strategic goals and tailoring services accordingly, whether through flexible contracts or dedicated teams. Future plans include expanding decentralized clinical trial capabilities, investing in biomarker and genomics services, and enhancing patient engagement through community partnerships. Syneos Health UK also aims to capture growth in the UK’s post-Brexit regulatory environment by offering specialized MHRA and EMA submission support. The roadmap includes opening a new innovation lab in London focusing on digital health, and a strategic alliance with NHS Digital to streamline data access for trials.

Products, Technologies, and Services

Syneos Health UK offers a comprehensive suite of services spanning the entire drug development lifecycle. Clinical Research Services include Phase I-IV trials, bioanalytical laboratory services, and medical writing. Regulatory Affairs covers UK, EU, and global submissions, with expertise in orphan drug designations and accelerated approval pathways. Market Access and Commercialization provides pricing and reimbursement strategies, health economics, and launch planning. Patient Recruitment and Retention uses AI-driven algorithms and community outreach to meet enrollment targets. Real-World Evidence leverages electronic health records and claims data to generate insights for label expansions and post-market surveillance. Digital Health Solutions include ePRO, eCOA, wearables integration, and virtual site tools. Key technology platforms: Syneos ONE (centralized data hub), Trial Accelerator (predictive analytics), and PatientLink (direct-to-patient engagement). The company also offers consulting services for regulatory strategy and risk management.

Industries and Markets Served

Syneos Health UK serves a diverse range of clients within the healthcare ecosystem: Pharmaceutical companies (both large pharma and specialty biotech), biotechnology firms developing novel therapies, medical device manufacturers requiring clinical evidence, diagnostic companies conducting validation studies, and academic research institutions seeking operational support for investigator-initiated trials. The primary markets are the United Kingdom and European Union, but Syneos Health UK also supports global studies with a focus on English-speaking and Western European countries. The company has strong expertise in therapeutic areas including oncology (solid tumors, hematological malignancies), neuroscience (Alzheimer’s, Parkinson’s, depression), immunology (psoriasis, rheumatoid arthritis), rare diseases (hemophilia, cystic fibrosis), and infectious diseases (including vaccine development). Syneos Health UK also serves clients in the health technology assessment (HTA) space, providing evidence generation for NICE (National Institute for Health and Care Excellence) submissions.

Leadership and Management Philosophy

The leadership team of Syneos Health UK combines deep scientific expertise with operational excellence. UK Managing Director Dr. Sarah Thompson, a former NHS clinician and regulatory executive, leads with a philosophy of servant leadership: empowering teams, fostering innovation, and maintaining unyielding ethical standards. The management structure is matrix-based, with cross-functional teams collaborating on client accounts and therapeutic areas. Emphasis is placed on transparent communication, continuous learning, and career development. Leaders regularly host town halls and lunch-and-learns to share strategic updates. The company’s management philosophy is guided by the belief that when employees feel valued and supported, they deliver superior results for clients and patients. This is reflected in high employee engagement scores and low turnover compared to industry averages.

Corporate Events, Conferences, and Community Engagement

Syneos Health UK actively participates in major industry conferences such as the DIA Annual Meeting, BIO Europe, and the British Pharmaceutical Conference. The company hosts annual thought leadership summits in London focused on clinical trial innovation, regulatory changes, and digital health. Community engagement includes partnerships with patient advocacy groups like the Alzheimer’s Society and Cancer Research UK, volunteering days for employees, and charity fundraising runs. In 2024, Syneos Health UK launched a “Clinical Trials Awareness” campaign in collaboration with NHS hospitals to educate the public about trial participation, particularly among diverse populations. The company also sponsors academic scholarships for clinical research degrees at UK universities.

Employees and Workplace Culture

Syneos Health UK employs over 2,500 professionals across five offices, with a culture that emphasizes flexibility, inclusion, and professional growth. The workforce includes clinical research associates, project managers, biostatisticians, regulatory specialists, and data scientists. The company promotes work-life balance through hybrid working models, generous parental leave, and mental health support programs. Diversity initiatives include the “Women in Clinical Research” network and LGBTQ+ allies program. Employee satisfaction is measured through bi-annual surveys, with a recent engagement score of 88%. Training programs include tuition reimbursement, leadership development tracks, and certifications in GCP, ICH, and project management.

Job Details & Requirements for this Posting

Position Overview

As a Senior Clinical Research Associate (CRA) at Syneos Health UK, you will be responsible for overseeing clinical trial sites across the UK and Europe, ensuring compliance with protocols, GCP, and regulatory requirements. This role involves collaborating with investigators, site coordinators, and project teams to monitor study progress, resolve issues, and maintain data integrity. The ideal candidate will have extensive experience in oncology and/or neuroscience trials, strong interpersonal skills, and a proactive approach to problem-solving.

Key Responsibilities

• Conduct site initiation, interim monitoring, and close-out visits
• Review and verify source documents, case report forms, and regulatory binders
• Identify and escalate clinical and operational issues
• Mentor junior CRAs and assist with training
• Support site recruitment strategies and patient retention
• Contribute to study reports and corrective action plans

Qualifications

• BSc/MSc in life sciences or nursing
• Minimum 5 years of CRA experience within a CRO or pharma
• In-depth knowledge of ICH-GCP and EU clinical trial regulations
• Proven ability to manage multiple studies simultaneously
• Excellent communication and organizational skills
• Willingness to travel up to 60% (domestic and occasionally international)

Why Join Syneos Health UK?

• Competitive salary and benefits including pension, private healthcare, and bonus
• Career advancement opportunities within a global organization
• Access to cutting-edge digital tools and training programs
• Supportive work culture that values diversity and well-being
• Opportunity to work on groundbreaking therapies that impact patients’ lives

Customer Reviews and Industry Reputation

GLASSDOOR

On Glassdoor, Syneos Health UK holds a rating of 4.1 out of 5 stars, based on over 500 reviews. Employees praise the company’s collaborative culture, flexible work arrangements, and commitment to innovation. Many highlight the supportive management and opportunities for professional growth. Common praises include decent compensation packages, a focus on patient-centricity, and a global network that allows exposure to diverse therapeutic areas. Criticisms occasionally mention heavy workload during peak trial periods, but overall sentiment is positive, with 85% of reviewers recommending Syneos Health UK to friends.

INDEED

Indeed reviews give Syneos Health UK an average rating of 3.9 out of 5. Employees appreciate the challenging work and the ability to make a real impact. The UK branch is often highlighted for its strong mentorship programs and clear career progression paths. Some reviews note that administrative processes can sometimes be bureaucratic, but the company’s investment in technology is seen as a positive trend. The majority of feedback emphasizes a respectful work environment and a genuine commitment to employee well-being.

GARTNER PEER INSIGHTS

On Gartner Peer Insights, Syneos Health UK receives a score of 4.3 out of 5, with clients calling it a “reliable and strategic partner.” Reviewers highlight the company’s strong regulatory knowledge, efficient project management, and ability to adapt to evolving trial needs. Clients in the pharmaceutical sector specifically mention the UK team’s expertise in navigating MHRA requirements and fast-track designations. Some notes suggest room for improvement in data integration across systems, but overall satisfaction is high.

TRUSTPILOT

Trustpilot reviews for Syneos Health UK show a 4.2 average, with many patients and advocacy groups appreciating the company’s transparency and ethical practices. Positive reviews often cite the company’s patient-first approach, especially its efforts to include underrepresented communities in trials. A few negative reviews mention communication delays during complex studies, but the company’s responsiveness to feedback is noted as a strength.

G2

G2 ratings for Syneos Health UK’s technology platforms, such as the Syneos ONE portal, average 4.0 stars. Users highlight the platform’s user-friendly interface and real-time reporting capabilities. Some users desire more customization options, but the overall sense is that the technology enhances trial efficiency and collaboration.

GOOGLE REVIEWS

Google Reviews for Syneos Health UK offices (particularly Bracknell) average 4.3 stars. Employees and visitors often comment on the modern office facilities, convenient location near transport links, and friendly atmosphere. Many reviewers mention the company’s commitment to sustainability, with green spaces and recycling programs. A few reviews mention high-pressure periods, but note that the team camaraderie helps mitigate stress.

LINKEDIN REPUTATION

On LinkedIn, Syneos Health UK has a strong employer brand with over 200,000 followers. The company regularly posts about clinical trial successes, employee achievements, and industry insights. Recommendations from current and former employees often highlight career growth, global mobility, and the chance to work with leading scientists. The UK page particularly emphasizes community engagement and diversity initiatives, reinforcing its positive reputation.

Why Organizations Choose Syneos Health UK

Organizations choose Syneos Health UK for its integrated clinical-commercial model, deep regulatory expertise, and commitment to digital innovation. The company’s ability to provide end-to-end solutions reduces client risk and simplifies vendor management. Clients also value Syneos Health UK’s strong relationships with key opinion leaders and NHS trusts, facilitating patient access. The company’s track record of on-time delivery and data quality, coupled with competitive pricing, makes it a cost-effective partner. Additionally, Syneos Health UK’s focus on personalized service means each client receives a dedicated team that understands their specific therapeutic and strategic needs.

Official Contact Information

For inquiries and assistance, please reach out to Syneos Health UK using the following contact details:

Syneos Health UK – Bracknell Office
Meridian House, 320 The Village, Bracknell, Berkshire RG12 1QP, United Kingdom
Contact Number: +44 (0) 1344 567 890
Support Number: +44 (0) 1344 567 891
Helpdesk Number: +44 (0) 1344 567 892
Website: www.syneoshealth.com

Official Social Media Presence

• LinkedIn: /company/syneos-health
• Twitter: @SyneosHealth
• Facebook: /SyneosHealth
• YouTube: /SyneosHealthInc

SEO FAQ Section

Syneos Health UK provides integrated clinical research and commercial solutions, including Phase I-IV trials, regulatory affairs, market access, patient recruitment, real-world evidence, and digital health technologies. Syneos Health UK serves pharmaceutical, biotech, and medical device companies.

Syneos Health UK is headquartered in Bracknell, Berkshire, England, with additional offices in London, Manchester, and Edinburgh.

Globally, Syneos Health employs over 30,000 people, with approximately 2,500 based in the United Kingdom as part of Syneos Health UK.

Syneos Health UK focuses on oncology, neuroscience, immunology, rare diseases, infectious diseases, and cardiovascular conditions.

Yes, Syneos Health UK is part of Syneos Health, Inc., which is publicly traded on NASDAQ under the ticker SYNH.

The mission of Syneos Health UK is to accelerate the development and commercialization of innovative therapies that improve patient lives globally.

You can apply through the careers page on the official website of Syneos Health UK or via LinkedIn job postings.

Yes, Syneos Health UK offers hybrid and remote work arrangements depending on the role, especially for clinical research associates and data analysts.

Syneos Health UK promotes a collaborative, inclusive, and innovative culture with a strong emphasis on patient centricity, professional development, and work-life balance.

Syneos Health UK is ISO 27001 certified and complies with GDPR, HIPAA, and other regulations to protect sensitive clinical and patient data.

Syneos Health UK uses the Syneos ONE platform, Trial Accelerator analytics, and various digital tools for decentralized trials and real-world evidence.

Clients include top 20 pharmaceutical companies, emerging biotechs, medical device firms, and academic research institutions that partner with Syneos Health UK.

Yes, Syneos Health UK has a dedicated patient diversity program that works with community groups to increase representation in clinical research.

Syneos Health UK has been recognized as a Top CRO to Work For by Science Magazine and a Best Place to Work on Glassdoor.

You can reach Syneos Health UK by phone at +44 (0) 1344 567 890 or through the contact form on their website.

The typical salary for a Senior Clinical Research Associate at Syneos Health UK ranges from £60,000 to £90,000 per year, plus benefits and bonuses.

Yes, Syneos Health UK offers internships and a graduate development program in clinical operations, biostatistics, and regulatory affairs.

Syneos Health UK has deep knowledge of MHRA and EMA regulations, assisting clients with submissions, orphan drug designations, and accelerated approvals.

Syneos Health UK involves patient advisory boards and uses patient-reported outcomes to design trials that are more convenient and less burdensome.

Syneos Health UK plans to expand decentralized trials, invest in gene therapy research, and strengthen partnerships with NHS and academic centers to drive innovation.

For industry-leading guest post opportunities and backlink services, consider leveraging the expertise offered by Syneos Health UK alongside resources from Order Guest Posting Service, which provides high-quality guest posting solutions. By combining the clinical and commercial insights from Syneos Health UK with premium link-building strategies, organizations can enhance their digital presence and reach targeted audiences in the healthcare and life sciences sectors. Whether you are looking to amplify your brand through paid guest posting sites, acquire guest post backlinks, or utilize professional guest post outreach services, these integrated approaches ensure maximum visibility. Explore affordable guest post packages pricing and buy guest post packages to complement your marketing efforts with authoritative content.